Skip to main content
SpringerLink
Log in

Adnexal Carcinoma: Microcystic Adnexal Carcinoma and Sebaceous Carcinoma

  • Chapter
  • First Online:
A Practical Guide to Skin Cancer

  • 1278 Accesses

Abstract

Microcystic adnexal carcinoma (MAC) and sebaceous carcinoma (SC) are rare adnexal neoplasms. MAC most commonly presents as a poorly defined, firm, skin-colored papule, nodule, or plaque on the head and neck. Although locally destructive, MAC does not typically metastasize. Rates of misdiagnosis are high, due to incomplete, superficial sampling. Resection techniques with meticulous margin control, including Mohs micrographic surgery (MMS), are recommended in the management of MAC.

Sebaceous carcinoma, originating from holocrine sebocytes, is often found on the head and neck and is among the most common eyelid neoplasms. SC commonly presents as a firm, subcutaneous nodule with a yellow hue. SC may masquerade as other neoplastic and inflammatory entities, delaying diagnosis. Patients with SC must be screened for Muir-Torre syndrome, a hereditary cancer syndrome. Treatment for SC is surgical. SC has metastatic potential, most commonly to draining lymph node basins. Radiation and chemotherapy play a role in the management of metastatic disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Goldstein DJ, Barr RJ, Santa Cruz DJ. Microcystic adnexal carcinoma: a distinct clinicopathologic entity. Cancer. 1982;50(3):566–72.

    Article  PubMed  CAS  Google Scholar 

  2. Pujol RM, LeBoit PE, Su WP. Microcystic adnexal carcinoma with extensive sebaceous differentiation. Am J Dermatopathol. 1997;19(4):358–62.

    Article  PubMed  CAS  Google Scholar 

  3. Nickoloff BJ, Fleischmann HE, Carmel J, Wood CC, Roth RJ. Microcystic adnexal carcinoma. Immunohistologic observations suggesting dual (pilar and eccrine) differentiation. Arch Dermatol. 1986;122(3):290–4.

    Article  PubMed  CAS  Google Scholar 

  4. Boos MD, Elenitsas R, Seykora J, Lehrer MS, Miller CJ, Sobanko J. Benign subclinical syringomatous proliferations adjacent to a microcystic adnexal carcinoma: a tumor mimic with significant patient implications. Am J Dermatopathol. 2014;36(2):174–8.

    Article  PubMed  Google Scholar 

  5. Cardoso JC, Calonje E. Malignant sweat gland tumours: an update. Histopathology. 2015;67(5):589–606.

    Article  PubMed  Google Scholar 

  6. Chiller K, Passaro D, Scheuller M, Singer M, McCalmont T, Grekin RC. Microcystic adnexal carcinoma: forty-eight cases, their treatment, and their outcome. Arch Dermatol. 2000;136(11):1355–9.

    PubMed  CAS  Google Scholar 

  7. Yu JB, Blitzblau RC, Patel SC, Decker RH, Wilson LD. Surveillance, Epidemiology, and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin. Am J Clin Oncol. 2010;33(2):125–7.

    Article  PubMed  Google Scholar 

  8. Diamantis SA, Marks VJ. Mohs micrographic surgery in the treatment of microcystic adnexal carcinoma. Dermatol Clin. 2011;29(2):185–90. viii.

    Article  PubMed  CAS  Google Scholar 

  9. Fu T, Clark FL, Lorenz HP, Bruckner AL. Congenital microcystic adnexal carcinoma. Arch Dermatol. 2011;147(2):256–7.

    Article  PubMed  Google Scholar 

  10. Peterson CM, Ratz JL, Sangueza OP. Microcystic adnexal carcinoma: first reported case in an African American man. J Am Acad Dermatol. 2001;45(2):283–5.

    Article  PubMed  CAS  Google Scholar 

  11. Nadiminti H, Nadiminti U, Washington C. Microcystic adnexal carcinoma in African-Americans. Dermatol Surg. 2007;33(11):1384–7.

    PubMed  CAS  Google Scholar 

  12. Ohtsuka H, Nagamatsu S. Microcystic adnexal carcinoma: review of 51 Japanese patients. Dermatology. 2002;204(3):190–3.

    Article  PubMed  Google Scholar 

  13. Chen J, Yang S, Liao T, Deng W, Li W. Microcystic adnexal carcinoma in a non-Caucasian patient: a case report and review of the literature. Oncol Lett. 2016;11(4):2471–4.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Tolkachjov SN, Schmitt AR, Muzic JG, Weaver AL, Baum CL. Incidence and clinical features of rare cutaneous malignancies in Olmsted County, Minnesota, 2000 to 2010. Dermatol Surg. 2017;43(1):116–24.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Wick MR, Cooper PH, Swanson PE, Kaye VN, Sun TT. Microcystic adnexal carcinoma. An immunohistochemical comparison with other cutaneous appendage tumors. Arch Dermatol. 1990;126(2):189–94.

    Article  PubMed  CAS  Google Scholar 

  16. Avraham JB, Villines D, Maker VK, August C, Maker AV. Survival after resection of cutaneous adnexal carcinomas with eccrine differentiation: risk factors and trends in outcomes. J Surg Oncol. 2013;108(1):57–62.

    Article  PubMed  Google Scholar 

  17. LeBoit PE, Sexton M. Microcystic adnexal carcinoma of the skin. A reappraisal of the differentiation and differential diagnosis of an underrecognized neoplasm. J Am Acad Dermatol. 1993;29(4):609–18.

    Article  PubMed  CAS  Google Scholar 

  18. Snow S, Madjar DD, Hardy S, Bentz M, Lucarelli MJ, Bechard R, et al. Microcystic adnexal carcinoma: report of 13 cases and review of the literature. Dermatol Surg. 2001;27(4):401–8.

    PubMed  CAS  Google Scholar 

  19. Carroll P, Goldstein GD, Brown CW. Metastatic microcystic adnexal carcinoma in an immunocompromised patient. Dermatol Surg. 2000;26(6):531–4.

    Article  PubMed  CAS  Google Scholar 

  20. Smith KJ, Williams J, Corbett D, Skelton H. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis. Am J Surg Pathol. 2001;25(4):464–71.

    Article  PubMed  CAS  Google Scholar 

  21. Wohlfahrt C, Ternesten A, Sahlin P, Islam Q, Stenman G. Cytogenetic and fluorescence in situ hybridization analyses of a microcystic adnexal carcinoma with del(6)(q23q25). Cancer Genet Cytogenet. 1997;98(2):106–10.

    Article  PubMed  CAS  Google Scholar 

  22. Kishi M, Nakamura M, Nishimine M, Ishida E, Shimada K, Kirita T, et al. Loss of heterozygosity on chromosome 6q correlates with decreased thrombospondin-2 expression in human salivary gland carcinomas. Cancer Sci. 2003;94(6):530–5.

    Article  PubMed  CAS  Google Scholar 

  23. Dupré A, Carrère S, Bonafé JL, Christol B, Lassère J, Touron P. Eruptive generalized syringomas, milium and atrophoderma vermiculata. Nicolau and Balus' syndrome (author's transl). Dermatologica. 1981;162(4):281–6.

    Article  PubMed  Google Scholar 

  24. Ranasinghe AR, Batchelor J, Ha T. Nicolau Balus syndrome with microcystic adnexal carcinoma. J Am Acad Dermatol. 2013;68(4):AB56.

    Google Scholar 

  25. Schaller J, Rytina E, Rütten A, Hendricks C, Ha T, Requena L. Sweat duct proliferation associated with aggregates of elastic tissue and atrophodermia vermiculata: a simulator of microcystic adnexal carcinoma. Report of two cases. J Cutan Pathol. 2010;37(9):1002–9.

    Article  PubMed  Google Scholar 

  26. Page RN, Hanggi MC, King R, Googe PB. Multiple microcystic adnexal carcinomas. Cutis. 2007;79(4):299–303.

    PubMed  Google Scholar 

  27. Leibovitch I, Huilgol SC, Selva D, Lun K, Richards S, Paver R. Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2005;52(2):295–300.

    Article  PubMed  Google Scholar 

  28. Connolly KL, Nehal KS, Disa JJ. Evidence-based medicine: cutaneous facial malignancies: nonmelanoma skin cancer. Plast Reconstr Surg. 2017;139(1):181e–90e.

    Article  PubMed  CAS  Google Scholar 

  29. Friedman PM, Friedman RH, Jiang SB, Nouri K, Amonette R, Robins P. Microcystic adnexal carcinoma: collaborative series review and update. J Am Acad Dermatol. 1999;41(2 Pt 1):225–31.

    Article  PubMed  CAS  Google Scholar 

  30. Yugueros P, Kane WJ, Goellner JR. Sweat gland carcinoma: a clinicopathologic analysis of an expanded series in a single institution. Plast Reconstr Surg. 1998;102(3):705–10.

    Article  PubMed  CAS  Google Scholar 

  31. Obaidat NA, Alsaad KO, Ghazarian D. Skin adnexal neoplasms--part 2: an approach to tumours of cutaneous sweat glands. J Clin Pathol. 2007;60(2):145–59.

    Article  PubMed  Google Scholar 

  32. Sellheyer K, Nelson P, Kutzner H, Patel RM. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers. J Cutan Pathol. 2013;40(4):363–70.

    Article  PubMed  Google Scholar 

  33. Fu JM, McCalmont T, Yu SS. Adenosquamous carcinoma of the skin: a case series. Arch Dermatol. 2009;145(10):1152–8.

    Article  PubMed  Google Scholar 

  34. Frouin E, Vignon-Pennamen MD, Balme B, Cavelier-Balloy B, Zimmermann U, Ortonne N, et al. Anatomoclinical study of 30 cases of sclerosing sweat duct carcinomas (microcystic adnexal carcinoma, syringomatous carcinoma and squamoid eccrine ductal carcinoma). J Eur Acad Dermatol Venereol. 2015;29(10):1978–94.

    Article  PubMed  CAS  Google Scholar 

  35. Sebastien TS, Nelson BR, Lowe L, Baker S, Johnson TM. Microcystic adnexal carcinoma. J Am Acad Dermatol. 1993;29(5 Pt 2):840–5.

    Article  PubMed  CAS  Google Scholar 

  36. Crowson AN, Magro CM, Mihm MC. Malignant adnexal neoplasms. Mod Pathol. 2006;19(Suppl 2):S93–S126.

    Article  PubMed  Google Scholar 

  37. Urso C, Bondi R, Paglierani M, Salvadori A, Anichini C, Giannini A. Carcinomas of sweat glands: report of 60 cases. Arch Pathol Lab Med. 2001;125(4):498–505.

    PubMed  CAS  Google Scholar 

  38. Merritt BG, Snow SN, Longley BJ. Desmoplastic trichoepithelioma, infiltrative/morpheaform BCC, and microcystic adnexal carcinoma: differentiation by immunohistochemistry and determining the need for Mohs micrographic surgery. Cutis. 2010;85(5):254–8.

    PubMed  Google Scholar 

  39. Costache M, Bresch M, Böer A. Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: a critical reappraisal of histomorphological and immunohistochemical criteria for differentiation. Histopathology. 2008;52(7):865–76.

    Article  PubMed  CAS  Google Scholar 

  40. Shinohara R, Ansai S, Ogita A, Matsuda H, Saeki H, Tanaka M. Dermoscopic findings of microcystic adnexal carcinoma. Eur J Dermatol. 2015;25(5):516–8.

    PubMed  CAS  Google Scholar 

  41. Hoang MP, Dresser KA, Kapur P, High WA, Mahalingam M. Microcystic adnexal carcinoma: an immunohistochemical reappraisal. Mod Pathol. 2008;21(2):178–85.

    Article  PubMed  CAS  Google Scholar 

  42. Nagatsuka H, Rivera RS, Gunduz M, Siar CH, Tamamura R, Mizukawa N, et al. Microcystic adnexal carcinoma with mandibular bone marrow involvement: a case report with immunohistochemistry. Am J Dermatopathol. 2006;28(6):518–22.

    Article  PubMed  Google Scholar 

  43. Krahl D, Sellheyer K. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma. J Cutan Pathol. 2007;34(10):782–7.

    Article  PubMed  Google Scholar 

  44. Abesamis-Cubillan E, El-Shabrawi-Caelen L, PE LB. Merked cells and sclerosing epithelial neoplasms. Am J Dermatopathol. 2000;22(4):311–5.

    Article  PubMed  CAS  Google Scholar 

  45. Patrizi A, Neri I, Marzaduri S, Varotti E, Passarini B. Syringoma: a review of twenty-nine cases. Acta Derm Venereol. 1998;78(6):460–2.

    Article  PubMed  CAS  Google Scholar 

  46. Salasche SJ, Amonette RA. Morpheaform basal-cell epitheliomas. A study of subclinical extensions in a series of 51 cases. J Dermatol Surg Oncol. 1981;7(5):387–94.

    Article  PubMed  CAS  Google Scholar 

  47. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(13):975–83.

    Article  PubMed  CAS  Google Scholar 

  48. Wang Q, Ghimire D, Wang J, Luo S, Li Z, Wang H, et al. Desmoplastic trichoepithelioma: a clinicopathological study of three cases and a review of the literature. Oncol Lett. 2015;10(4):2468–76.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Popadić M. Dermoscopy of aggressive basal cell carcinomas. Indian J Dermatol Venereol Leprol. 2015;81(6):608–10.

    Article  PubMed  Google Scholar 

  50. Tawfik AM, Kreft A, Wagner W, Vogl TJ. MRI of a microcystic adnexal carcinoma of the skin mimicking a fibrous tumour: case report and literature review. Br J Radiol. 2011;84(1002):e114–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  51. Gomez-Maestra MJ, España-Gregori E, Aviñó-Martinez JA, Mancheño-Franch N, Peña S. Brainstem and cavernous sinus metastases arising from a microcystic adnexal carcinoma of the eyebrow by perineural spreading. Can J Ophthalmol. 2009;44(3):e17–8.

    Article  PubMed  Google Scholar 

  52. Beltramini GA, Baj A, Moneghini L, Poli T, Combi VA, Giannì AB. Microcystic adnexal carcinoma of the centrofacial region: a case report. Acta Otorhinolaryngol Ital. 2010;30(4):213.

    PubMed  PubMed Central  CAS  Google Scholar 

  53. Cooper PH, Mills SE, Leonard DD, Santa Cruz DJ, Headington JT, Barr RJ, et al. Sclerosing sweat duct (syringomatous) carcinoma. Am J Surg Pathol. 1985;9(6):422–33.

    Article  PubMed  CAS  Google Scholar 

  54. Abbate M, Zeitouni NC, Seyler M, Hicks W, Loree T, Cheney RT. Clinical course, risk factors, and treatment of microcystic adnexal carcinoma: a short series report. Dermatol Surg. 2003;29(10):1035–8.

    PubMed  Google Scholar 

  55. Palamaras I, McKenna JD, Robson A, Barlow RJ. Microcystic adnexal carcinoma: a case series treated with mohs micrographic surgery and identification of patients in whom paraffin sections may be preferable. Dermatol Surg. 2010;36(4):446–52.

    Article  PubMed  CAS  Google Scholar 

  56. Lopez M, Cole EL. Microcystic adnexal carcinoma: reconstruction of a large centrofacial defect. Plast Reconstr Surg Glob Open. 2014;2(11):e254.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Eisen DB, Zloty D. Microcystic adnexal carcinoma involving a large portion of the face: when is surgery not reasonable? Dermatol Surg. 2005;31(11 Pt 1):1472–7. discussion 8.

    PubMed  CAS  Google Scholar 

  58. Rotter N, Wagner H, Fuchshuber S, Issing WJ. Cervical metastases of microcystic adnexal carcinoma in an otherwise healthy woman. Eur Arch Otorhinolaryngol. 2003;260(5):254–7.

    PubMed  Google Scholar 

  59. Green M, Mitchum M, Marquart J, Bowden LP, Bingham J. Microcystic adnexal carcinoma in the axilla of an 18-year-old woman. Pediatr Dermatol. 2014;31(6):e145–8.

    Article  PubMed  Google Scholar 

  60. Ban M, Sugie S, Kamiya H, Kitajima Y. Microcystic adnexal carcinoma with lymph node metastasis. Dermatology. 2003;207(4):395–7.

    Article  PubMed  Google Scholar 

  61. Gulmen S, Pullon PA. Sweat gland carcinoma of the lips. Oral Surg Oral Med Oral Pathol. 1976;41(5):643–9.

    Article  PubMed  CAS  Google Scholar 

  62. Stein JM, Ormsby A, Esclamado R, Bailin P. The effect of radiation therapy on microcystic adnexal carcinoma: a case report. Head Neck. 2003;25(3):251–4.

    Article  PubMed  Google Scholar 

  63. Baxi S, Deb S, Weedon D, Baumann K, Poulsen M. Microcystic adnexal carcinoma of the skin: the role of adjuvant radiotherapy. J Med Imaging Radiat Oncol. 2010;54(5):477–82.

    Article  PubMed  Google Scholar 

  64. Yuh WT, Engelken JD, Whitaker DC, Dolan KD. Bone marrow invasion of microcystic adnexal carcinoma. Ann Otol Rhinol Laryngol. 1991;100(7):601–3.

    Article  PubMed  CAS  Google Scholar 

  65. Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL. Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol. 2005;50(2):103–22.

    Article  PubMed  Google Scholar 

  66. Tripathi R, Chen Z, Li L, Bordeaux JS. Incidence and survival of sebaceous carcinoma in the United States. J Am Acad Dermatol. 2016;75(6):1210–5.

    Article  PubMed  Google Scholar 

  67. Doxanas MT, Green WR. Sebaceous gland carcinoma. Review of 40 cases. Arch Ophthalmol. 1984;102(2):245–9.

    Article  PubMed  CAS  Google Scholar 

  68. Kyllo RL, Brady KL, Hurst EA. Sebaceous carcinoma: review of the literature. Dermatol Surg. 2015;41(1):1–15.

    Article  PubMed  CAS  Google Scholar 

  69. Ponti G, Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol. 2005;6(12):980–7.

    Article  PubMed  Google Scholar 

  70. Dores GM, Curtis RE, Toro JR, Devesa SS, Fraumeni JF. Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome. Cancer. 2008;113(12):3372–81.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Nelson BR, Hamlet KR, Gillard M, Railan D, Johnson TM. Sebaceous carcinoma. J Am Acad Dermatol. 1995;33(1):1–15. quiz 6-8.

    Article  PubMed  CAS  Google Scholar 

  72. Natarajan K, Rai R, Pillai SB. Extra ocular sebaceous carcinoma: a rare case report. Indian Dermatol Online J. 2011;2(2):91–3.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Brady KL, Hurst EA. Sebaceous carcinoma treated with Mohs micrographic surgery. Dermatol Surg. 2017;43(2):281–6.

    Article  PubMed  CAS  Google Scholar 

  74. Slutsky JB, Jones EC. Periocular cutaneous malignancies: a review of the literature. Dermatol Surg. 2012;38(4):552–69.

    Article  PubMed  CAS  Google Scholar 

  75. Pereira PR, Odashiro AN, Rodrigues-Reyes AA, Correa ZM, de Souza Filho JP, Burnier MN. Histopathological review of sebaceous carcinoma of the eyelid. J Cutan Pathol. 2005;32(7):496–501.

    Article  PubMed  Google Scholar 

  76. Reifler DM, Hornblass A. Squamous cell carcinoma of the eyelid. Surv Ophthalmol. 1986;30(6):349–65.

    Article  PubMed  CAS  Google Scholar 

  77. Nemoto Y, Arita R, Mizota A, Sasajima Y. Differentiation between chalazion and sebaceous carcinoma by noninvasive meibography. Clin Ophthalmol. 2014;8:1869–75.

    PubMed  PubMed Central  Google Scholar 

  78. Coates D, Bowling J, Haskett M. Dermoscopic features of extraocular sebaceous carcinoma. Australas J Dermatol. 2011;52(3):212–3.

    Article  PubMed  Google Scholar 

  79. Rao NA, Hidayat AA, McLean IW, Zimmerman LE. Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol. 1982;13(2):113–22.

    Article  PubMed  CAS  Google Scholar 

  80. Ni C, Searl SS, Kuo PK, Chu FR, Chong CS, Albert DM. Sebaceous cell carcinomas of the ocular adnexa. Int Ophthalmol Clin. 1982;22(1):23–61.

    Article  PubMed  CAS  Google Scholar 

  81. Yin VT, Merritt HA, Sniegowski M, Esmaeli B. Eyelid and ocular surface carcinoma: diagnosis and management. Clin Dermatol. 2015;33(2):159–69.

    Article  PubMed  CAS  Google Scholar 

  82. Wali UK, Al-Mujaini A. Sebaceous gland carcinoma of the eyelid. Oman J Ophthalmol. 2010;3(3):117–21.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Cook BE, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology. 1999;106(4):746–50.

    Article  PubMed  Google Scholar 

  84. Dasgupta T, Wilson LD, Yu JB. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer. 2009;115(1):158–65.

    Article  PubMed  Google Scholar 

  85. Blake PW, Bradford PT, Devesa SS, Toro JR. Cutaneous appendageal carcinoma incidence and survival patterns in the United States: a population-based study. Arch Dermatol. 2010;146(6):625–32.

    Article  PubMed  Google Scholar 

  86. Wolfe JT, Yeatts RP, Wick MR, Campbell RJ, Waller RR. Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis. Am J Surg Pathol. 1984;8(8):597–606.

    Article  PubMed  Google Scholar 

  87. Dowd MB, Kumar RJ, Sharma R, Murali R. Diagnosis and management of sebaceous carcinoma: an Australian experience. ANZ J Surg. 2008;78(3):158–63.

    Article  PubMed  Google Scholar 

  88. Kass LG, Hornblass A. Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol. 1989;33(6):477–90.

    Article  PubMed  CAS  Google Scholar 

  89. Sung D, Kaltreider SA, Gonzalez-Fernandez F. Early onset sebaceous carcinoma. Diagn Pathol. 2011;6:81.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  90. Kivelä T, Asko-Seljavaara S, Pihkala U, Hovi L, Heikkonen J. Sebaceous carcinoma of the eyelid associated with retinoblastoma. Ophthalmology. 2001;108(6):1124–8.

    Article  PubMed  Google Scholar 

  91. Abdi U, Tyagi N, Maheshwari V, Gogi R, Tyagi SP. Tumours of eyelid: a clinicopathologic study. J Indian Med Assoc. 1996;94(11):405. -9, 16, 18.

    PubMed  CAS  Google Scholar 

  92. Kiyosaki K, Nakada C, Hijiya N, Tsukamoto Y, Matsuura K, Nakatsuka K, et al. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid. Invest Ophthalmol Vis Sci. 2010;51(1):7–11.

    Article  PubMed  Google Scholar 

  93. Hussain RM, Matthews JL, Dubovy SR, Thompson JM, Wang G. UV-independent p53 mutations in sebaceous carcinoma of the eyelid. Ophthal Plast Reconstr Surg. 2014;30(5):392–5.

    Article  PubMed  Google Scholar 

  94. Gonzalez-Fernandez F, Kaltreider SA, Patnaik BD, Retief JD, Bao Y, Newman S, et al. Sebaceous carcinoma. Tumor progression through mutational inactivation of p53. Ophthalmology. 1998;105(3):497–506.

    Article  PubMed  CAS  Google Scholar 

  95. Shalin SC, Sakharpe A, Lyle S, Lev D, Calonje E, Lazar AJ. p53 staining correlates with tumor type and location in sebaceous neoplasms. Am J Dermatopathol. 2012;34(2):129–35. quiz 36-8.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Hayashi N, Furihata M, Ohtsuki Y, Ueno H. Search for accumulation of p53 protein and detection of human papillomavirus genomes in sebaceous gland carcinoma of the eyelid. Virchows Arch. 1994;424(5):503–9.

    Article  PubMed  CAS  Google Scholar 

  97. Cho KJ, Khang SK, Koh JS, Chung JH, Lee SS. Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein. J Korean Med Sci. 2000;15(5):545–50.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  98. Stagner AM, Afrogheh AH, Jakobiec FA, Iacob CE, Grossniklaus HE, Deshpande V, et al. p16 expression is not a surrogate marker for high-risk human papillomavirus infection in periocular sebaceous carcinoma. Am J Ophthalmol. 2016;170:168–75.

    Article  PubMed  CAS  Google Scholar 

  99. Kwon MJ, Shin HS, Nam ES, Cho SJ, Lee MJ, Lee S, et al. Comparison of HER2 gene amplification and KRAS alteration in eyelid sebaceous carcinomas with that in other eyelid tumors. Pathol Res Pract. 2015;211(5):349–55.

    Article  PubMed  CAS  Google Scholar 

  100. Liau JY, Liao SL, Hsiao CH, Lin MC, Chang HC, Kuo KT. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age. Hum Pathol. 2014;45(3):533–9.

    Article  PubMed  CAS  Google Scholar 

  101. Landis MN, Davis CL, Bellus GA, Wolverton SE. Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy. J Am Acad Dermatol. 2011;65(5):1054–8.e1.

    Article  PubMed  Google Scholar 

  102. Hoss E, Nelson SA, Sharma A. Sebaceous carcinoma in solid organ transplant recipients. Int J Dermatol. 2017;56:746.

    Article  PubMed  Google Scholar 

  103. Yen MT, Tse DT. Sebaceous cell carcinoma of the eyelid and the human immunodeficiency virus. Ophthal Plast Reconstr Surg. 2000;16(3):206–10.

    Article  PubMed  CAS  Google Scholar 

  104. Rumelt S, Hogan NR, Rubin PA, Jakobiec FA. Four-eyelid sebaceous cell carcinoma following irradiation. Arch Ophthalmol. 1998;116(12):1670–2.

    Article  PubMed  CAS  Google Scholar 

  105. Hood IC, Qizilbash AH, Salama SS, Young JE, Archibald SD. Sebaceous carcinoma of the face following irradiation. Am J Dermatopathol. 1986;8(6):505–8.

    Article  PubMed  CAS  Google Scholar 

  106. Schlernitzauer DA, Font RL. Sebaceous gland carcinoma of the eyelid. Arch Ophthalmol. 1976;94(9):1523–5.

    Article  PubMed  CAS  Google Scholar 

  107. Izumi M, Tang X, Chiu CS, Nagai T, Matsubayashi J, Iwaya K, et al. Ten cases of sebaceous carcinoma arising in nevus sebaceus. J Dermatol. 2008;35(11):704–11.

    Article  PubMed  Google Scholar 

  108. Wenzel CT, Halperin EC, Fisher SR. Second malignant neoplasms of the head and neck in survivors of retinoblastoma. Ear Nose Throat J. 2001;80(2):106, 9–12.

    PubMed  CAS  Google Scholar 

  109. Lemos LB, Santa Cruz DJ, Baba N. Sebaceous carcinoma of the eyelid following radiation therapy. Am J Surg Pathol. 1978;2(3):305–11.

    Article  PubMed  CAS  Google Scholar 

  110. Howrey RP, Lipham WJ, Schultz WH, Buckley EG, Dutton JJ, Klintworth GK, et al. Sebaceous gland carcinoma: a subtle second malignancy following radiation therapy in patients with bilateral retinoblastoma. Cancer. 1998;83(4):767–71.

    Article  PubMed  CAS  Google Scholar 

  111. John AM, Schwartz RA. Muir-Torre syndrome (MTS): an update and approach to diagnosis and management. J Am Acad Dermatol. 2016;74(3):558–66.

    Article  PubMed  Google Scholar 

  112. Mahalingam M. MSH6, past and present and Muir-Torre syndrome-connecting the dots. Am J Dermatopathol. 2017;39(4):239–49.

    Article  PubMed  Google Scholar 

  113. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995;33(1):90–104.

    Article  PubMed  CAS  Google Scholar 

  114. Jessup CJ, Redston M, Tilton E, Reimann JD. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome. Hum Pathol. 2016;49:1–9.

    Article  PubMed  CAS  Google Scholar 

  115. Sinicrope FA, Sargent DJ. Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications. Clin Cancer Res. 2012;18(6):1506–12.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  116. Cohen PR, Kohn SR, Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med. 1991;90(5):606–13.

    Article  PubMed  CAS  Google Scholar 

  117. Lazar AJ, Lyle S, Calonje E. Sebaceous neoplasia and Torre-Muir syndrome. Curr Diagn Pathol. 2007;13(4):301–19.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  118. Bhaijee F, Brown AS. Muir-Torre syndrome. Arch Pathol Lab Med. 2014;138(12):1685–9.

    Article  PubMed  Google Scholar 

  119. Grob A, Feser C, Grekin S. Muir-torre syndrome:a case associated with an infrequent gene mutation. J Clin Aesthet Dermatol. 2016;9(1):56–9.

    PubMed  PubMed Central  Google Scholar 

  120. Singh RS, Grayson W, Redston M, Diwan AH, Warneke CL, McKee PH, et al. Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia. Am J Surg Pathol. 2008;32(6):936–42.

    Article  PubMed  Google Scholar 

  121. Zürcher M, Hintschich CR, Garner A, Bunce C, Collin JR. Sebaceous carcinoma of the eyelid: a clinicopathological study. Br J Ophthalmol. 1998;82(9):1049–55.

    Article  PubMed  PubMed Central  Google Scholar 

  122. Demirci H, Nelson CC, Shields CL, Eagle RC, Shields JA. Eyelid sebaceous carcinoma associated with Muir-Torre syndrome in two cases. Ophthal Plast Reconstr Surg. 2007;23(1):77–9.

    Article  PubMed  Google Scholar 

  123. Wick MR, Goellner JR, Wolfe JT, Su WP. Adnexal carcinomas of the skin. II. Extraocular sebaceous carcinomas. Cancer. 1985;56(5):1163–72.

    Article  PubMed  CAS  Google Scholar 

  124. Hou JL, Killian JM, Baum CL, Otley CC, Roenigk RK, Arpey CJ, et al. Characteristics of sebaceous carcinoma and early outcomes of treatment using Mohs micrographic surgery versus wide local excision: an update of the Mayo Clinic experience over the past 2 decades. Dermatol Surg. 2014;40(3):241–6.

    Article  PubMed  CAS  Google Scholar 

  125. Cook BE, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001;108(11):2088–98; quiz 99–100, 121.

    Article  PubMed  Google Scholar 

  126. Shields JA, Demirci H, Marr BP, Eagle RC, Shields CL. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology. 2004;111(12):2151–7.

    Article  PubMed  Google Scholar 

  127. Wang JK, Liao SL, Jou JR, Lai PC, Kao SC, Hou PK, et al. Malignant eyelid tumours in Taiwan. Eye (Lond). 2003;17(2):216–20.

    Article  Google Scholar 

  128. Husain A, Blumenschein G, Esmaeli B. Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid. Int J Dermatol. 2008;47(3):276–9.

    Article  PubMed  Google Scholar 

  129. Muqit MM, Roberts F, Lee WR, Kemp E. Improved survival rates in sebaceous carcinoma of the eyelid. Eye (Lond). 2004;18(1):49–53.

    Article  CAS  Google Scholar 

  130. Boniuk M, Zimmerman LE. Sebaceous carcinoma of the eyelid, eyebrow, caruncle, and orbit. Trans Am Acad Ophthalmol Otolaryngol. 1968;72(4):619–42.

    PubMed  CAS  Google Scholar 

  131. Sawyer AR, McGoldrick RB, Mackey S, Powell B, Pohl M. Should extraocular sebaceous carcinoma be investigated using sentinel node biopsy? Dermatol Surg. 2009;35(4):704–8.

    Article  PubMed  CAS  Google Scholar 

  132. Rulon DB, Helwig EB. Cutaneous sebaceous neoplasms. Cancer. 1974;33(1):82–102.

    Article  PubMed  CAS  Google Scholar 

  133. Chang AY, Miller CJ, Elenitsas R, Newman JG, Sobanko JF. Management considerations in extraocular sebaceous carcinoma. Dermatol Surg. 2016;42(Suppl 1):S57–65.

    Article  PubMed  CAS  Google Scholar 

  134. Shalin SC, Lyle S, Calonje E, Lazar AJ. Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications. Histopathology. 2010;56(1):133–47.

    Article  PubMed  PubMed Central  Google Scholar 

  135. Font R. Eyelids and lacrimal drainage system. In: Spencer WH, editor. Ophthalmic pathology: an atlas and textbook. 3rd ed. Philadelphia: WB Saunders; 1986. p. 2169–214.

    Google Scholar 

  136. Pfeiffer ML, Yin VT, Myers J, Esmaeli B. Regional nodal recurrence of sebaceous carcinoma of the caruncle 11 years after primary tumor resection. JAMA Ophthalmol. 2013;131(8):1091–2.

    Article  PubMed  Google Scholar 

  137. Kohler S, Rouse RV, Smoller BR. The differential diagnosis of pagetoid cells in the epidermis. Mod Pathol. 1998;11(1):79–92.

    PubMed  CAS  Google Scholar 

  138. Sramek B, Lisle A, Loy T. Immunohistochemistry in ocular carcinomas. J Cutan Pathol. 2008;35(7):641–6.

    Article  PubMed  Google Scholar 

  139. Beer TW, Shepherd P, Theaker JM. Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathology. 2000;37(3):218–23.

    Article  PubMed  CAS  Google Scholar 

  140. Ansai SI. Topics in histopathology of sweat gland and sebaceous neoplasms. J Dermatol. 2017;44(3):315–26.

    Article  PubMed  CAS  Google Scholar 

  141. Rajan Kd A, Burris C, Iliff N, Grant M, Eshleman JR, Eberhart CG. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma. Am J Ophthalmol. 2014;157(3):640–7.e1–2.

    Article  PubMed  CAS  Google Scholar 

  142. Buitrago W, Joseph AK. Sebaceous carcinoma: the great masquerader: emerging concepts in diagnosis and treatment. Dermatol Ther. 2008;21(6):459–66.

    Article  PubMed  Google Scholar 

  143. Esmaeli B, Nasser QJ, Cruz H, Fellman M, Warneke CL, Ivan D. American joint committee on cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. Ophthalmology. 2012;119(5):1078–82.

    Article  PubMed  Google Scholar 

  144. American Joint Committee on Cancer. New York, NY: Springer; 2010.

    Google Scholar 

  145. Reina RS, Parry E. Aggressive extraocular sebaceous carcinoma in a 52-year-old man. Dermatol Surg. 2006;32(10):1283–6.

    PubMed  CAS  Google Scholar 

  146. Orcurto A, Gay BE, Sozzi WJ, Gilliet M, Leyvraz S. Long-term remission of an aggressive sebaceous carcinoma following chemotherapy. Case Rep Dermatol. 2014;6(1):80–4.

    Article  PubMed  PubMed Central  Google Scholar 

  147. Herceg D, Kusacić-Kuna S, Dotlić S, Petrović R, Bracić I, Horvatić Herceg G, et al. F-18 FDG PET evaluation of a rapidly growing extraocular sebaceous carcinoma. Clin Nucl Med. 2009;34(11):798–801.

    Article  PubMed  Google Scholar 

  148. Baek CH, Chung MK, Jeong HS, Son YI, Choi J, Kim YD, et al. The clinical usefulness of (18)F-FDG PET/CT for the evaluation of lymph node metastasis in periorbital malignancies. Korean J Radiol. 2009;10(1):1–7.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Ginsberg J. Present status of meibomian gland carcinoma. Arch Ophthalmol. 1965;73:271–7.

    Article  PubMed  CAS  Google Scholar 

  150. Erovic BM, Goldstein DP, Kim D, Al Habeeb A, Waldron J, Ghazarian D, et al. Sebaceous gland carcinoma of the head and neck: the Princess Margaret Hospital experience. Head Neck. 2013;35(3):316–20.

    Article  PubMed  Google Scholar 

  151. Bailet JW, Zimmerman MC, Arnstein DP, Wollman JS, Mickel RA. Sebaceous carcinoma of the head and neck. Case report and literature review. Arch Otolaryngol Head Neck Surg. 1992;118(11):1245–9.

    Article  PubMed  CAS  Google Scholar 

  152. Tryggvason G, Bayon R, Pagedar NA. Epidemiology of sebaceous carcinoma of the head and neck: implications for lymph node management. Head Neck. 2012;34(12):1765–8.

    Article  PubMed  Google Scholar 

  153. Ho VH, Ross MI, Prieto VG, Khaleeq A, Kim S, Esmaeli B. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg. 2007;133(8):820–6.

    Article  PubMed  Google Scholar 

  154. Nijhawan N, Ross MI, Diba R, Ahmadi MA, Esmaeli B. Experience with sentinel lymph node biopsy for eyelid and conjunctival malignancies at a cancer center. Ophthal Plast Reconstr Surg. 2004;20(4):291–5.

    Article  PubMed  Google Scholar 

  155. Savar A, Oellers P, Myers J, Prieto VG, Torres-Cabala C, Frank SJ, et al. Positive sentinel node in sebaceous carcinoma of the eyelid. Ophthal Plast Reconstr Surg. 2011;27(1):e4–6.

    Article  PubMed  Google Scholar 

  156. Harrington CR, Egbert BM, Swetter SM. Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome. Dermatol Surg. 2004;30(5):817–9.

    PubMed  Google Scholar 

  157. Pfeiffer ML, Savar A, Esmaeli B. Sentinel lymph node biopsy for eyelid and conjunctival tumors: what have we learned in the past decade? Ophthal Plast Reconstr Surg. 2013;29(1):57–62.

    Article  PubMed  Google Scholar 

  158. Spencer JM, Nossa R, Tse DT, Sequeira M. Sebaceous carcinoma of the eyelid treated with Mohs micrographic surgery. J Am Acad Dermatol. 2001;44(6):1004–9.

    Article  PubMed  CAS  Google Scholar 

  159. Grigoryan KV, Leithauser L, Gloster HM. Aggressive extraocular sebaceous carcinoma recurring after mohs micrographic surgery. Case Rep Oncol Med. 2015;2015:534176.

    PubMed  PubMed Central  Google Scholar 

  160. Callahan EF, Appert DL, Roenigk RK, Bartley GB. Sebaceous carcinoma of the eyelid: a review of 14 cases. Dermatol Surg. 2004;30(8):1164–8.

    PubMed  Google Scholar 

  161. Dogru M, Matsuo H, Inoue M, Okubo K, Yamamoto M. Management of eyelid sebaceous carcinomas. Ophthalmologica. 1997;211(1):40–3.

    Article  PubMed  CAS  Google Scholar 

  162. Snow SN, Larson PO, Lucarelli MJ, Lemke BN, Madjar DD. Sebaceous carcinoma of the eyelids treated by mohs micrographic surgery: report of nine cases with review of the literature. Dermatol Surg. 2002;28(7):623–31.

    PubMed  Google Scholar 

  163. Cavanagh HD, Green WR, Goldberg HK. Multicentric sebaceous adenocarcinoma of the meibomian gland. Am J Ophthalmol. 1974;77(3):326–32.

    Article  PubMed  CAS  Google Scholar 

  164. Nunery WR, Welsh MG, McCord CD. Recurrence of sebaceous carcinoma of the eyelid after radiation therapy. Am J Ophthalmol. 1983;96(1):10–5.

    Article  PubMed  CAS  Google Scholar 

  165. Hendley RL, Rieser JC, Cavanagh HD, Bodner BI, Waring GO. Primary radiation therapy for meibomian gland carcinoma. Am J Ophthalmol. 1979;87(2):206–9.

    Article  PubMed  CAS  Google Scholar 

  166. Hata M, Koike I, Omura M, Maegawa J, Ogino I, Inoue T. Noninvasive and curative radiation therapy for sebaceous carcinoma of the eyelid. Int J Radiat Oncol Biol Phys. 2012;82(2):605–11.

    Article  PubMed  Google Scholar 

  167. Yen MT, Tse DT, Wu X, Wolfson AH. Radiation therapy for local control of eyelid sebaceous cell carcinoma: report of two cases and review of the literature. Ophthal Plast Reconstr Surg. 2000;16(3):211–5.

    Article  PubMed  CAS  Google Scholar 

  168. Pardo FS, Wang CC, Albert D, Stracher MA. Sebaceous carcinoma of the ocular adnexa: radiotherapeutic management. Int J Radiat Oncol Biol Phys. 1989;17(3):643–7.

    Article  PubMed  CAS  Google Scholar 

  169. Jung YH, Woo IS, Kim MY, Han CW, Rha EY. Palliative 5-fluorouracil and cisplatin chemotherapy in recurrent metastatic sebaceous carcinoma: case report and literature review. Asia Pac J Clin Oncol. 2016;12(1):e189–93.

    Article  PubMed  Google Scholar 

  170. Murthy R, Honavar SG, Burman S, Vemuganti GK, Naik MN, Reddy VA. Neoadjuvant chemotherapy in the management of sebaceous gland carcinoma of the eyelid with regional lymph node metastasis. Ophthal Plast Reconstr Surg. 2005;21(4):307–9.

    Article  PubMed  Google Scholar 

  171. Priyadarshini O, Biswas G, Biswas S, Padhi R, Rath S. Neoadjuvant chemotherapy in recurrent sebaceous carcinoma of eyelid with orbital invasion and regional lymphadenopathy. Ophthal Plast Reconstr Surg. 2010;26(5):366–8.

    Article  PubMed  Google Scholar 

  172. Paschal BR, Bagley CS. Sebaceous land carcinoma of the eyelid: complete response to sequential combination chemotherapy. N C Med J. 1985;46(9):473–4.

    PubMed  CAS  Google Scholar 

  173. el Nakadi B, Nouwynck C, Salhadin A. Combined therapeutic approach for extraorbital sebaceous carcinoma in a Torre's syndrome. Eur J Surg Oncol. 1995;21(3):321–2.

    Article  PubMed  Google Scholar 

  174. De Leo A, Innocenzi D, Onesti MG, Potenza C, Toscani M, Scuderi N. Extraocular sebaceous carcinoma in Muir Torre Syndrome with unfavorable prognosis. Cancer Chemother Pharmacol. 2006;58(6):842–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Dermatology, Dell Medical School, University of Texas at Austin, Austin, TX, USA

    Paul R. Massey, Anthony C. Soldano & Matthew C. Fox

Authors
  1. Paul R. Massey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony C. Soldano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthew C. Fox
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul R. Massey .

Editor information

Editors and Affiliations

  1. Department of Medicine, Division of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA

    Allison Hanlon

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Massey, P.R., Soldano, A.C., Fox, M.C. (2018). Adnexal Carcinoma: Microcystic Adnexal Carcinoma and Sebaceous Carcinoma. In: Hanlon, A. (eds) A Practical Guide to Skin Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-74903-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74903-7_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74901-3

  • Online ISBN: 978-3-319-74903-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation